Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Parvalbumin isoforms for enhancing cardiac diastolic function.

Wang Wang¹, Joseph M Metzger

¹Department of Molecular and Integrative Physiology, University of Michigan Medical School, 1301 E. Catherine St., 7727 Medical Science II, Ann Arbor, MI 48109-0622, USA.

Cell Biochemistry and Biophysics

|May 7, 2008

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Engineering Human Myocardium: Integrating the Maturation of hiPSC-Derived Cardiac Myocytes Across Genetic, Structural, Physiological and Multicellular Systems.

Cells·2026

Same author

Synthetic bottlebrush block copolymer prevents disease onset in Duchenne muscular dystrophy.

Proceedings of the National Academy of Sciences of the United States of America·2025

Same author

Elucidating cancer cachexia-mediated aberrant cardiac wasting signaling in human iPSC-derived cardiac muscle.

bioRxiv : the preprint server for biology·2025

Same author

Biaxial length-tension relationship in single cardiac myocytes.

Biophysical journal·2025

Same author

OsZNHIT3 functions as a transcriptional activator to regulate tapetal programmed cell death and exine formation in rice.

The New phytologist·2025

Same author

HIF-1α: A Key Factor Mediating Tumor Cells from Digestive System to Evade NK Cell Killing via Activating Metalloproteinases to Hydrolyze MICA/B.

Biomolecules·2025

Same journal

From Isoprene Units to Polyprenols and Dolichols: 70 Years of Polyisoprenoid Biosynthesis Research.

Cell biochemistry and biophysics·2026

Same journal

Therapeutic Insights into the Hepatoprotective Effect of Strobilanthes callosa.

Cell biochemistry and biophysics·2026

Same journal

The Dual Role of TGF-β and Hypoxia on MMP14-Mediated Invasion in PC3 Cells.

Cell biochemistry and biophysics·2026

Same journal

Microalgae-Mediated Synthesis of Gold Nanoparticles from Indonesian Chlorella vulgaris InaCC M205 with Potential Anticancer Properties for Biomedical Application.

Cell biochemistry and biophysics·2026

Same journal

Adsorption-driven Graphene Oxide SPR Biointerfaces: Coupled Thermodynamic, Kinetic, and Optical Modeling with Effective-layer Validation.

Cell biochemistry and biophysics·2026

Same journal

Identification of Ferroptosis-related Genes Associated with the Prognosis of Hepatocellular Carcinoma.

Cell biochemistry and biophysics·2026

See all related articles

Parvalbumin (Parv) gene transfer accelerates myocardial relaxation and corrects diastolic dysfunction in diastolic heart failure (DHF). This approach targets calcium handling defects, offering a novel therapeutic strategy for DHF patients.

Area of Science:

Cardiovascular Physiology
Molecular Cardiology
Genetic Therapeutics

Background:

Diastolic heart failure (DHF) affects nearly half of heart failure patients with preserved ejection fraction.
Impaired myocardial relaxation and ventricular filling in DHF are linked to defective intracellular calcium (Ca2+) handling.
Current therapeutic strategies for DHF remain limited.

Purpose of the Study:

To review the rationale and development of parvalbumin (Parv) gene transfer for DHF.
To discuss the impact of Parv isoforms on cardiac Ca2+ handling and function.
To explore Parv as a therapeutic target for diastolic dysfunction.

Main Methods:

Review of existing literature on parvalbumin and diastolic heart failure.
Analysis of genetic manipulation strategies involving Ca2+ handling proteins.

Related Experiment Videos

Discussion of in vitro and in vivo studies on parvalbumin's effects.

Main Results:

Ectopic expression of parvalbumin accelerates myocardial relaxation.
Parvalbumin acts as a 'delayed' Ca2+ buffer, promoting Ca2+ transient decay.
Parv corrects diastolic dysfunction in an energy-independent manner.

Conclusions:

Parvalbumin gene transfer represents a promising therapeutic approach for DHF.
Understanding Parv isoform-specific effects is crucial for optimizing treatment.
This strategy aims to alleviate diastolic dysfunction by improving Ca2+ handling.